about
Central Serous Chorioretinopathy Treatments: A Mini ReviewDexamethasone intravitreal implant in the treatment of diabetic macular edemaReview and perspectives on pharmacological vitreolysisPharmacological approach to diabetic macular edemaPhotodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia.The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.Early vascular changes induced by transpupillary thermotherapy of choroidal neovascularization.Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy.Ultrastructural analysis of rabbit retina irradiated with a new 670-nm diode red laser at different powers.Diurnal variation in clinically significant diabetic macular edema measured by the Stratus OCT.Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration.Guidance for the treatment of neovascular age-related macular degeneration.Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.Branch retinal vein occlusion: classification and treatment.Treatment of serous pigment epithelium detachment with subthreshold micropulse diode laser photocoagulation: a case report.Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.Antivascular endothelial growth factor in diabetic retinopathy.Retinal vein occlusion: current treatment.Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema.Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II studyA Review of Current and Future Management of Geographic Atrophy.Temporary intraocular pressure lowering by photodynamic therapy in pseudoexfoliation glaucoma.Experience with the PascalĀ® photocoagulator: an analysis of over 1,200 laser procedures with regard to parameter refinement.Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema.Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).Intravitreal dexamethasone implant in patients with persistent diabetic macular edema.Optical coherence tomography in tadalafil-associated retinal toxicity.Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.Retinal nerve fiber layer thickness reproducibility using seven different OCT instruments.Treatment options for diffuse diabetic macular edema.Pathophysiology and treatment of diabetic retinopathy.Intravitreal bevacizumab for retinal neovascularizations associated with myelinated nerve fibers.Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.Bilateral choroidal excavation in best vitelliform macular dystrophy.Practical management of retinal vein occlusions.Update of intravitreal steroids for the treatment of diabetic macular edema.Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse.
P50
Q26775968-3A175611-F732-4050-9A4D-0549B58EF261Q26799423-9D02A3E5-A338-4405-A499-D8E0242DF66BQ26829640-50412949-1F28-4DC0-9D31-0CA13212EBE5Q27024091-FECD0A22-0171-45DA-9426-3390E689EA3BQ30728383-345BF8DD-7E06-4880-A6F8-DBF6E05FEB8EQ31061150-7863B759-E08D-4197-BBEB-5D316AA6A3FEQ32123663-5777CF36-C5F3-4E4D-A0E8-57C2C0D45923Q33200982-21921D56-7CE6-4E3D-B497-AC582B2E6798Q33229048-9AEAD39E-9412-4928-AF23-739F7D4DE415Q33230950-D86EDCD2-D937-4164-A3C0-126636829540Q33242781-99E9F23C-1B0D-4DAD-85B9-74250D289ECEQ33251628-5CFC8FC1-4235-4C27-8ADC-78E16FF0FC97Q33291861-FB34B7DC-F3EE-4FA0-A24C-3F4999398BADQ33396800-9FD505C6-3087-4B1F-834B-BFA080491254Q33431156-8166B415-092A-469F-8CE8-A325AF200A1AQ33507337-66381A52-4E21-4456-B263-F912DB1C2040Q33530302-27E7458C-1422-4A78-9434-0E92803FC35DQ33655139-A9DAC43F-EEAF-471C-936C-E02E579E7E22Q33715353-8E2E2237-C25D-4A1C-BB2B-2F51856AF689Q33720888-B8986E2E-4FCC-4520-82DF-D0A952D4589EQ33730079-BCDC4B6B-2B5A-48DC-BD63-39E105F44EB1Q33740158-252A3F68-383E-460E-84E0-D606641920E6Q33758546-3282AF32-E94E-48D4-AA6F-BF0F4C0FBAF7Q33829567-65B53C1C-E97B-4542-881C-C78B9267A663Q33836612-8A359F0D-A651-4545-8068-817C78FFD757Q33860909-C5B936C8-8102-4D55-A0DB-2D1B4A818144Q34037627-D967FCDB-9ED9-4BB1-ADCE-C5BC411382D8Q34092454-8A8E876E-FA8C-4B0C-BABA-600C1522A32FQ34152161-E79633F8-0167-44CB-A3F7-28370DAB029CQ34157067-7D82A96E-C2C3-4EBF-996C-4AA445F2D216Q34201060-0DC4EE42-45FB-48E7-A270-BB1459539DFBQ34370306-C13D2C68-D37B-4CBB-BFB8-59CFF59728E1Q34522193-D6A1B5AD-93D1-47BF-B9F7-208B3ACA6352Q34528134-A250EC96-16A2-4B80-A0C9-86D3A68938DCQ34567377-BF43B9DA-17B8-4722-8803-8E14C84416D6Q34969574-C61B1DA0-7917-471A-956A-BB61BFF4CAF5Q35090004-DC0C98E1-C720-480D-A717-66221F365DACQ35227614-42BBA64D-64E9-4B42-B53E-73EFCB7D1D94Q35241177-22C9AACE-2F1C-46EF-8238-2CF6F77973CBQ35241177-FBEDECB5-1F9E-4846-8ADC-39A710288434
P50
description
researcher ORCID ID = 0000-0003-3238-9682
@en
name
Francesco Bandello
@ast
Francesco Bandello
@en
Francesco Bandello
@es
Francesco Bandello
@nl
type
label
Francesco Bandello
@ast
Francesco Bandello
@en
Francesco Bandello
@es
Francesco Bandello
@nl
prefLabel
Francesco Bandello
@ast
Francesco Bandello
@en
Francesco Bandello
@es
Francesco Bandello
@nl
P1006
P214
P244
P1006
P21
P214
P244
P31
P496
0000-0003-3238-9682
P5008
P569
1950-01-01T00:00:00Z
P735
P7859
lccn-n95802065